DALLAS (2019) – White Rock Advisors, LLC is pleased to announce it recently advised Prevalent Health (“Prevalent”) on its sale to iMedX, Inc. (“iMedX”), a portfolio company of RFE Investment Partners, a private equity firm based in Connecticut.
Founded in 2006 by Shawn Fry, Prevalent is a cutting-edge healthcare information technology company based in Houston, TX. Through their proprietary technology Prevalent can analyze any healthcare providers data and build custom data analytics and dashboards necessary to manage the business of healthcare.
Founded in 2002, iMedX is an integrated medical document management and health information solutions company based in Atlanta, GA. Through its continuously growing technological capabilities, iMedX offers a full suite of high-value revenue cycle management solutions including medical transcription and coding services, results-based consulting, education and training opportunities, and data analytics. The acquisition of Prevalent will allow iMedX to deliver custom technology solutions and drive positive results and success for thousands of healthcare clients globally.
Shawn Fry, CEO and Founder of Prevalent, stated, “This was a real team effort, and we could not have got this deal over the goal line without the expertise and assistance of White Rock Advisors. I am extremely excited to move forward as the Chief Innovation Officer with iMedX and deploy the technology we created at Prevalent on a broader and global scale.
Gabe Trotta, Director at White Rock Advisors added, “We are pleased to see the successful combination of these companies thanks to the hard work of everyone involved. We believe the improved technology and analytics capabilities of iMedX will improve outcomes for many people in the healthcare space.”
